A carregar...

How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders

Medications that affect the renin–angiotensin–aldosterone system (RAAS) form the mainstay of current heart failure (HF) therapy in patients with reduced ejection fraction. Concerns about the risk of hyperkalaemia have created a significant barrier to optimal RAAS inhibitor therapy in patients with H...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Card Fail Rev
Autor principal: Lainscak, Mitja
Formato: Artigo
Idioma:Inglês
Publicado em: Radcliffe Cardiology 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494153/
https://ncbi.nlm.nih.gov/pubmed/28785473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/cfr.2017.2.1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!